HSG Billing in Fertility Practices: CPT Codes and Denial Prevention

Hysterosalpingography (HSG) is one of the first diagnostic procedures performed in a standard infertility workup, and its billing consistently generates questions — and denials — that fertility practice billing staff have not fully systematized. Unlike IVF or embryo transfer, HSG does not have a dedicated fertility CPT code; it borrows from radiology. That cross-category placement creates friction at every step: benefit routing, prior authorization determination, diagnosis code selection, and modifier application. This guide covers every billing variable a fertility practice needs to manage for HSG claims to pay on first submission.

What Makes HSG Billing Different from Other Fertility Procedure Claims

HSG sits at the intersection of diagnostic radiology and fertility medicine. The procedure involves fluoroscopic guidance, iodinated contrast injection, and clinical interpretation — functions that may be split among a radiologist, a fertility physician, and a facility. That split is responsible for the most common HSG billing errors: wrong code selection based on imaging modality, missing or incorrect modifiers when professional and technical components are billed separately, and diagnosis codes that send the claim to the wrong benefit tier.

The second complexity is structural: there is no dedicated CPT code for HSG catheter placement the way there is for saline infusion sonohysterography (SIS). For SIS, the physician separately bills CPT 58340 (catheterization and introduction of saline or contrast material) alongside the imaging code 76831. For fluoroscopic HSG, catheterization and contrast injection are included within CPT 74740 — the single code for hysterosalpingography, radiological supervision and interpretation. This distinction is foundational to correct HSG billing, and misapplying the SIS model to an HSG encounter is one of the most consistently recurring errors billing auditors find in fertility practice revenue cycles.

CPT Code Selection: Fluoroscopic HSG vs. Sonohysterography (SIS)

The distinction between 74740 (fluoroscopic HSG) and 76831 + 58340 (SIS) determines everything downstream — including how payers route the claim, whether it falls under a radiology or OB/GYN benefit tier, and what documentation the payer will request on audit. A practice billing 58340 alongside 74740 is overcoding: 58340 is specific to saline infusion sonohysterography and is not a recognized companion code to the fluoroscopic HSG code. This error is common when billing staff apply a SIS charge capture template to an HSG encounter without verifying the imaging modality used.

How HSG Is Billed When the Fertility Practice Controls the Procedure

The billing scenario changes depending on where the HSG takes place and which entity controls the imaging equipment. There are four common arrangements in fertility practices, each with different coding implications:

• Fertility clinic with in-house fluoroscopy equipment: The practice bills 74740 globally (no modifier), reflecting both the technical resources — fluoroscope, contrast materials, room, and staff — and the physician's formal interpretation. This is uncommon; most fertility practices do not own fluoroscopic C-arm equipment. When this arrangement applies, the practice must maintain appropriate radiology accreditation and equipment documentation to support the global claim.
• Fertility clinic referring to a hospital outpatient radiology department: The hospital bills 74740-TC for the equipment and staff. The interpreting radiologist bills 74740-26 for the professional component. The referring fertility physician does not bill anything for the HSG itself — any billable encounter relates only to the office visit at which the procedure was ordered or results were reviewed.
• Fertility physician performing HSG at an ASC: The ASC bills the facility fee using CPT 74740 on a UB-04. The performing or interpreting physician bills 74740-26 on a CMS-1500 for the professional component. ASC settings may trigger different authorization requirements than office-based or hospital outpatient procedures, depending on the payer.
• Fertility physician performing and interpreting at a hospital: If the REI physician places the catheter and provides the formal interpretation, they bill 74740-26 against the hospital's 74740-TC. The physician cannot bill 74740 globally when the imaging equipment belongs to the outside facility — this constitutes overcoding and is among the most commonly cited HSG billing errors in OIG guidance on split-billing diagnostic imaging.

ICD-10 Diagnosis Code Selection for HSG

Diagnosis code sequencing for HSG follows the same rule that applies to all diagnostic imaging in infertility billing: lead with the reason the test was ordered today, not the patient's eventual treatment destination. A patient who will ultimately proceed to IVF should not have Z31.83 (encounter for ART) as the primary code on an HSG claim unless that HSG is an explicit component of an already-authorized ART treatment cycle. If the HSG is a standalone diagnostic study — even one that will inform a future IVF decision — Z31.41 or a condition-specific infertility code is the correct primary diagnosis.

Diagnostic Benefit vs. Fertility Benefit: Which One Pays for HSG?

This is the central billing decision for every HSG claim at a fertility practice. HSG is a diagnostic imaging study. When billed correctly under Z31.41 or N97.x with code 74740, most commercial payers process HSG under the general medical or diagnostic imaging benefit — not the fertility benefit. That distinction matters enormously for two reasons: the diagnostic benefit typically carries no annual or lifetime treatment limits, and prior authorization is frequently not required for a diagnostic radiologic study ordered by a physician.

Prior Authorization for HSG

Under most major commercial payers, fluoroscopic HSG billed as a diagnostic imaging study under CPT 74740 does not require prior authorization when the primary diagnosis is Z31.41 or a condition-specific infertility code. However, several scenarios warrant verification before the appointment is scheduled:

• Fertility benefit manager involvement: If the patient has an active fertility benefit through Progyny, WINFertility, Carrot, or another FBM, HSG may be managed under that benefit even when the practice would prefer it route to major medical. Confirm the patient's complete benefit structure at eligibility verification and determine whether HSG falls under major medical or the FBM benefit before the procedure is ordered.
• Payer-specific radiology management programs: Some payers require authorization for fluoroscopic imaging through a radiology benefit manager. Aetna has historically used Carelon (formerly AIM Specialty Health) for radiology authorization, and fluoroscopic procedures may require clearance through that vendor even when no fertility-specific prior auth is needed. Verify through the payer's radiology management pathway separately from any fertility authorization line.
• Medicare patients: Traditional Medicare does not cover HSG for fertility indications. If HSG is ordered for a covered non-fertility indication — abnormal uterine bleeding, suspected structural anomaly unrelated to fertility — the diagnosis on both the order and the claim must reflect the covered indication. A fertility-coded HSG claim will be denied under Medicare. Obtain the correct indication from the physician before submitting.
• Repeat HSG within 12–24 months of a prior study: Some payers flag repeat HSG studies within a defined look-back period and require documentation of medical necessity. If a second HSG is ordered — after tuboplasty, proximal tubal occlusion reversal, or because a prior study was technically inconclusive — prepare a physician letter of medical necessity at the time of ordering rather than waiting for a post-submission denial to prompt the appeal process.
• High-deductible health plans: HDHPs process HSG normally under the diagnostic benefit, but the patient may owe a significant amount before the deductible is satisfied. This does not affect authorization, but it directly affects patient financial counseling and should be addressed at scheduling, not at checkout after the procedure is complete.

Common HSG Denial Reasons and How to Prevent Them

• 74740 denied as fertility-related exclusion: Occurs when Z31.83 or another ART diagnosis code triggers fertility-benefit adjudication at a payer that excludes fertility treatment. Prevention: use Z31.41 as primary on all standalone diagnostic HSG claims. If the payer denies Z31.41 as fertility-related, appeal with documentation that 74740 is a diagnostic imaging study evaluating uterine and tubal anatomy — not a fertility treatment procedure. Include the AMA code descriptor in the appeal.
• Claim denied for lack of medical necessity: Occurs when the physician order lacks a documented clinical indication. Prevention: the HSG order and pre-procedure visit note must both state the specific clinical question being answered — for example, "evaluate bilateral tubal patency and uterine cavity integrity as part of initial infertility workup." The documented indication must map cleanly to the ICD-10 code on the claim.
• 74740-26 denied because radiologist billed 74740 globally: Occurs when the fertility physician submits a professional component claim but the radiology group at the hospital already billed the global code. Prevention: establish a written billing arrangement with the radiology department before the first procedure. The agreement must specify that the practice will bill -26 and the facility will bill only -TC. Communicate this to radiology billing before every new patient referral.
• 58340 denied as unbundled from 74740: Occurs when billing staff apply a SIS charge template to a fluoroscopic HSG encounter. Prevention: 58340 is not a valid companion code to 74740. For fluoroscopic HSG, bill only 74740. For SIS, bill 76831 + 58340. These are mutually exclusive code sets for distinct procedures and must have completely separate charge capture templates that cannot be cross-applied.
• HSG and SIS denied as duplicate services on the same date: If 74740 and 76831 both appear on claims for the same patient on the same date of service — which can occur if both studies were genuinely performed — provide documentation of each distinct procedure and append modifier 59 to the second code to indicate separate, distinct services with independent clinical indication.
• Patient balance-billed by out-of-network radiologist at an in-network facility: The fertility practice refers to an in-network hospital, but the interpreting radiologist may belong to a physician group that is out-of-network for the patient's plan. While the fertility practice is not responsible for this billing arrangement, it generates patient complaints and erodes trust. Identify which radiologists are in-network for your major payer panels before establishing referral relationships.

Documentation Requirements That Support HSG Claims

• Physician order with explicit clinical indication: The order must state why the study is being performed — "evaluate for tubal patency and uterine cavity integrity as part of infertility workup" is sufficient; vague orders create audit vulnerability even when the claim initially processes. The indication must be mappable to the ICD-10 code on the claim.
• Pre-procedure visit note: The visit note in which HSG was discussed and ordered must document the patient's infertility history, any prior pelvic surgery or pathology, and the clinical decision to order HSG. This note establishes medical necessity at the encounter level and is the first document a payer requests during a medical necessity review.
• HSG report or formal interpretation: Whether generated by a radiologist or the interpreting fertility physician, the written report must identify uterine cavity findings, each fallopian tube individually (right and left — patent or occluded), peritoneal spill at the fimbriae, and any incidental findings. Bilateral documentation matters; payers may query whether a procedure implying bilateral evaluation is supported by bilateral findings in the written report.
• Informed consent documentation: Signed consent for HSG is standard of care and is required by many payer contracts and accreditation bodies for invasive diagnostic procedures. Maintain consent documentation in the procedure record and ensure it is retrievable if the claim goes to audit.
• Fluoroscopy time log: When the procedure is performed at the practice's facility, fluoroscopy time must be logged in the procedure record. This supports the technical component claim and may be requested on audit of the global or TC billing.
• Results communication note: A brief note documenting that the physician reviewed HSG results with the patient and made a specific clinical decision — proceeded to IVF, referred for hysteroscopy, planned repeat study — closes the medical necessity loop for the care episode and supports downstream authorization requests that reference the HSG findings.

Downstream Billing After HSG Confirms Tubal Factor or Uterine Pathology

The HSG result changes the ICD-10 landscape for all subsequent encounters. When HSG confirms bilateral tubal occlusion, all downstream infertility care shifts to N97.1 (female infertility of tubal origin) as the primary diagnosis driving IVF authorization requests, office visit claims, and referral documentation. When HSG reveals a uterine structural finding, the confirmed pathology should be coded at subsequent encounters using the specific finding: N84.0 for intrauterine polyp, D25.0 for submucosal fibroid, N85.6 for intrauterine synechiae, or Q51.3 for bicornuate uterus.

Fertility practices that do not update the ICD-10 code set in the patient's billing profile after a confirmed HSG finding will continue defaulting to N97.9 (unspecified) on subsequent claims, forfeiting the specificity that strengthens prior authorization medical necessity reviews. Build an HSG result processing step into the clinical workflow: within 48 hours of the report being finalized, a designated staff member should update the billing profile with the confirmed diagnosis. For IVF authorization requests that follow an HSG confirming tubal factor, the authorization letter should explicitly reference the HSG report date and finding — payer reviewers look for this connection when evaluating medical necessity for IVF.

SIS vs. HSG: When the Code Must Change Based on the Procedure Performed

Some fertility practices have shifted toward saline infusion sonohysterography (SIS) as a first-line uterine cavity evaluation, particularly for pre-IVF assessment when the clinical question is primarily intrauterine pathology rather than tubal patency. From a billing standpoint, SIS (76831 + 58340) and fluoroscopic HSG (74740) are distinct and not interchangeable on a claim. A practice that orders an HSG but performs a SIS must bill the SIS codes — not 74740. Billing the originally ordered code rather than the code matching the procedure actually performed is a billing error that creates audit exposure regardless of intent.

HSG provides superior information about tubal patency and peritoneal spill at the fimbriae; SIS provides better visualization of intrauterine pathology such as polyps, fibroids, synechiae, and uterine septum. The clinical choice of modality determines the CPT code, and the code drives downstream benefit routing, authorization determination, and documentation requirements. If a patient is consented for an HSG but the physician elects to perform SIS at the time of service, both the medical record and the claim must reflect the procedure actually performed.

Building a Charge Capture Workflow for HSG

Most charge capture failures for HSG trace to three workflow gaps: no separate charge template distinguishing HSG from SIS, no automatic modifier check based on procedure location, and no post-result step to update the billing profile when HSG findings change the ICD-10 landscape. An effective HSG charge capture process addresses all three:

• Separate charge templates for 74740 (HSG) and 76831 + 58340 (SIS): Never use a single imaging procedure template for both. The imaging modality must be confirmed before charge entry, and the template should include a required field for procedure location — office with in-house fluoroscopy, hospital outpatient, or ASC — that auto-populates the correct modifier logic.
• Modifier decision logic by location: If location is office with in-house fluoroscopy, default to 74740 global (no modifier). If location is hospital outpatient or ASC, default to 74740-26 for the physician claim and flag for facility coordination. Build this as a required selection field so billing staff cannot complete the charge without confirming the procedure setting.
• ICD-10 default set by encounter type: Distinguish between new patient infertility workup encounters (default primary Z31.41) and pre-cycle evaluations in patients with an established diagnosis (N97.8 or N97.1 based on the active chart). This prevents the Z31.83 default error on diagnostic claims. A required selection — standalone diagnostic or part of an authorized ART cycle — should determine which diagnosis set loads in the template.
• Post-result billing profile update step: Assign a staff member to review HSG reports within 48 hours of finalization. If the report confirms a specific finding — tubal occlusion, uterine anomaly, intrauterine pathology — the billing profile and any pending authorization supporting documentation should update in the same workflow step. This single addition prevents months of claims defaulting to N97.9 after a specific diagnosis has been established in the record.

HSG billing is not technically complex compared to multi-cycle IVF or PGT claims, but it concentrates errors in the areas of the revenue cycle that are hardest to catch after submission: benefit routing determined at diagnosis code entry, modifier selection based on procedure location, and downstream ICD-10 updating based on results. A practice that builds these three workflow controls into its charge capture process will reach a first-pass acceptance rate above 90% on HSG claims and minimize appeal activity on a procedure category that should essentially never require dispute resolution.